Newsletter | March 18, 2020

03.18.20 -- 7 Questions To Ask When Selecting A Site Payment Vendor


What characteristics and skills can you develop to improve communication channels with your CROs and sites? Join Clinical Leader Live on Tuesday April 7, 2020, for a virtual conference examining how your style, approach, and active listening skills can help alleviate the communication breakdown and, in turn, improve trial quality. Register.

Featured Editorial
7 Questions To Ask When Selecting A Site Payment Vendor
By Débora S. Araujo

The ability of clinical study sponsors to make investigator site payments accurately, on time, and with the appropriate level of details has long been an industry pain point. Sixty-six percent of investigator sites report having less than three months’ operating cash on hand, with lengthy delays in site payments resulting in high turnover rates among clinical investigators.

How To Find And Vet The Right Clinical Technology Vendor

In November 2019 Clinical Leader Live was proud to feature Larry Florin, president at LBF BioPharma Consulting, to discuss how clinical operations executives can “Overcome The Challenges of a Clinical Technology Implementation.” During the presentation Florin covered several topics, including how to be a champion for the technology, how to determine your technology selection team, addressing your to-do list, and managing enthusiasm. In this video, Florin discusses how to find and vet the right clinical technology vendor.

Industry Insights
How To Make The Patient Voice Heard In The Legislative Process
Article | By Steve Smith, WCG

Patients and their advocates can — and do! — use their collective voice to promote transformation through the legislative process. It can be a protracted process, but it can yield dramatic changes in policy that speed drug development and enhance safety.

Building In Quality To Design Trials For Change
Article | By Mark Gasdaska, Cenduit LLC

Sponsors want to achieve increasingly ambitious research goals in a growing number of indications, across geographies and global patient populations, faster than ever before, driving the need for increasing flexibility to adapt and change studies. Read how an experienced IRT provider can keep the day-to-day operations running smoothly as unanticipated protocol amendments arise.

Eight Sponsor Essentials For A Successful Clinical Trial
Article | By Jennifer Dennis-Wall, Ph.D., Biorasi

Without some key commitments from the sponsor, study success is far from guaranteed. These commitments ensure that sponsor and CRO move in concert to achieve a clear and well-defined goal — moving your clinical development program in the right direction.

Business And Cultural Considerations When Managing Clinical Supplies For Asia-Pacific Studies
Article | By Michele Stokes, Catalent

In addition to careful adherence with all applicable regulatory and customs requirements, sponsors should understand and be sensitive to the cultural and business norms of each country included in their study.

The 3 Cs You Should Expect From Your Pharma Service Provider
White Paper | By Yves Massicotte, Ropack Pharma Solutions

When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.  

Five Easy Investigator Payment Fixes To Improve Site Relations
White Paper | By Ryan Womer and Danielle E. Rodgers, IQVIA

Investigator payments have long been a challenge for both sponsors and sites because the process is complex, fragmented, lacking in transparency, and without standardization. This white paper reviews five common issues that delay site payments and offers recommendations to resolve these issues, improve payment efficiencies, and ultimately site satisfaction.

Approach Your Risk-Based Monitoring Strategy With Confidence
White Paper | Clinical Ink

Implementing a risk-based monitoring (RBM) strategy at your organization does not need to be complicated. This paper outlines several key strategies that will allow you to confidently develop an effective RBM approach in your clinical research program.

Large Global Phase 3 Clinical Trial In Metastatic Colorectal Carcinoma
Case Study | United BioSource LLC (UBC)

UBC was tasked with managing a large global Phase 3 clinical trial in patients with metastatic colorectal carcinoma (mCRC) refractory to standard chemotherapies. Read how patient enrollment was completed three months ahead of schedule and database lock 3.5 months ahead of schedule.

  Impact Of COVID-19 On Clinical Trials

Wednesday, March 25, 2020 | 11:00 AM EST

Registration is open for this free ClinBiz Virtual event on the Impact of COVID-19 on Clinical Trials. The event will have industry leaders from both pharma/biotech study sponsors, investigator sites and industry expert consultants as part of a great panel discussion on the COVID-19 impact on clinical trials and what different organizations are doing to ensure clinical trial continuity.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader: